Press release
Cytokine Market Accelerates with Immuno-Oncology Pipeline & U.S.-Japan R&D Alliances | CytoAgents, Cullinan Oncology, Inc, Genentech, Inc, AbbVie Inc
Cytokine Market
Cytokine Market Report by DataM Intelligence offers a detailed assessment of the global immunology and biologics landscape, highlighting market size, key players, and critical growth drivers. With a focus on cytokine-modulating biologics, diagnostics for hyperinflammation, and repurposed small-molecule inhibitors, the report delivers strategic insights for stakeholders from 2025 to 2033.
In 2025, high-impact reviews and translational initiatives from U.S. centers (and dedicated cytokine research consortia) renewed focus on biomarkers and targeted therapies for cytokine storm syndromes, accelerating investment into precision diagnostics and repurposing trials.
Download exclusive insights with our detailed sample report (Corporate Email ID gets priority access): https://www.datamintelligence.com/download-sample/cytokine-market?ophp
Cytokine Market Competitors Overview:
CytoAgents, Cullinan Oncology, Inc, Genentech, Inc, AbbVie Inc, Sanofi, Novartis AG, Pfizer Inc, F. Hoffmann-La Roche Ltd , Merck KGaA, GenScript and among others.
Important Industry Updates:
On March 27, 2023, The U.S. Food and Drug Administration (FDA) has approved CLN-617, a fusion protein composed of two potent and synergistic antitumor cytokines, IL-2 and IL-12, with a collagen binding domain intended for retention in the tumour microenvironment (TME) after intratumoral injection, according to Cullinan Oncology, Inc., a biopharmaceutical company focused on modality-agnostic targeted oncology therapies. In a Phase 1 trial, Cullinan Oncology will initially assess CLN-617 in patients with advanced solid tumours.
On June 15, 2023, Genentech, a member of the Roche Group, announced that the FDA had approved Columvi (glofitamab-gxbm) for the treatment of adult patients with relapsed or refractory (R/R) diffuse large B-cell lymphoma (DLBCL) that is not otherwise specified or large B-cell lymphoma (LBCL) arising from follicular lymphoma, following two or more lines of systemic therapy.
On May 19, 2023, The FDA has approved EPKINLYTM (epcoritamab-bysp), the first and only T-cell engaging bispecific antibody, for the treatment of adult patients with diffuse large B-cell lymphoma (DLBCL), not otherwise specified (NOS), including DLBCL resulting from indolent lymphoma, and high-grade B-cell lymphoma (HGBL), following two or more lines of systemic therapies.
Methodology and Scope
The Cytokine Market Report is built on a rigorous research methodology that integrates primary interviews, expert insights, and validated secondary data from company reports, industry publications, and reliable databases. Utilizing both bottom-up and top-down approaches, the analysis ensures high data accuracy through triangulation. The report covers current market dynamics, growth opportunities, and key strategic developments across global and regional markets.
Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/cytokine-market?ophp
Cytokine Market Segments Overview:
∎ By Type
Chemokines
Interferons
Interleukins
Tumor necrosis factor (TNF)
Monokines
Lymphokines
Colony-stimulating factors (CSF)
∎ By Application
Cancer
Orthopedic
Dermatology
Others
∎ By End Users
Pharmaceutical & Biotechnology Companies
Contract Research Organizations
Research Institutes
Others
Regional Overview for Cytokine Market:
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Looking for in-depth insights? Grab the full report: https://www.datamintelligence.com/buy-now-page?report=cytokine-market
The Report Covers:
➡ In-depth analysis of the demand-supply gap, market size estimates, SWOT and PESTEL analysis, along with global market forecasts.
➡ Strategic recommendations with a focused go-to-market approach.
➡ An unbiased evaluation of overall market performance.
➡ Region- and country-specific insights, with customized reports available upon request.
➡ Identification of high-potential and niche segments and regions demonstrating strong growth prospects.
People Also Ask:
➤ What are the current global trends in sales, production, imports, and exports within the Cytokine market?
➤ Who are the leading manufacturers, and what are their production volumes, pricing strategies, and revenue metrics?
➤ What are the major opportunities and challenges facing vendors in this market?
➤ Which product categories, applications, or end-user segments are contributing most to market growth and share?
➤ What are the primary factors driving and restraining growth in the Cytokine market?
Unlock 360° Market Intelligence with 2 Days FREE Trial Access of DataM Subscription Now!: https://www.datamintelligence.com/reports-subscription?ophp
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Pipeline Analysis For Drugs Discovery
✅ Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Competitive Landscape
Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cytokine Market Accelerates with Immuno-Oncology Pipeline & U.S.-Japan R&D Alliances | CytoAgents, Cullinan Oncology, Inc, Genentech, Inc, AbbVie Inc here
News-ID: 4142691 • Views: …
More Releases from DataM intelligence 4 Market Research LLP
Intelligent Emergency Response Systems and Infrastructure Market Rises as AI Dis …
The global Intelligent Emergency Response Systems and Infrastructure (IRSI) market was valued at US$ 1.3 billion in 2022 and is projected to reach US$ 2.1 billion by 2031, growing at a CAGR of 6.1% during the forecast period from 2024 to 2031. Market growth is driven by increasing investments in smart public safety infrastructure, AI-powered emergency response systems, and the rising need for disaster preparedness and real-time incident management.The Intelligent…
Anti-Senescence Therapeutics Market Moves From Longevity Hype Toward Biomarker-L …
The global anti-senescence therapeutics market was valued at USD 33.03 billion in 2025 and is projected to reach USD 53.39 billion by 2033, growing at a CAGR of 6.7% during the forecast period from 2026 to 2033. Market growth is driven by increasing investments in longevity research, rising prevalence of age-related diseases, and advancements in regenerative medicine and senolytic therapies. The Anti-Senescence Therapeutics Market is entering a new phase of…
Molecular Biosensors Market Accelerates as Point-of-Care Testing Moves Toward Fa …
The global Molecular Biosensors Market was valued at USD 30.80 billion in 2024, increased to USD 33.55 billion in 2025, and is estimated to reach USD 36.55 billion in 2026. The market is projected to grow to USD 56.04 billion by 2031, registering a CAGR of 8.93% during the forecast period from 2026 to 2031. These advanced sensing technologies combine molecular recognition with highly sensitive detection systems, enabling clinicians to…
ECG Patches and Holter Monitor Market Expands as Remote Cardiac Monitoring Shift …
The Global ECG Patches and Holter Monitor Market reached US$ 1,864.54 million in 2024 and is projected to grow to US$ 5,950.62 million by 2033, expanding at a CAGR of 13.7% during the forecast period (2025-2033). This robust growth reflects the increasing shift from short-term, wearable monitoring solutions that enable earlier detection of arrhythmias and other heart rhythm disorders. Advances in wearable ECG patches, cloud-connected monitoring platforms, and AI-assisted…
More Releases for Cytokine
Cytokine Release Syndrome Market New Product Development & Latest Trends
Introduction
Cytokine release syndrome (CRS) is a systemic inflammatory response triggered by an excessive activation of the immune system, leading to a surge of pro-inflammatory cytokines. While CRS can occur in severe infections and autoimmune conditions, it has gained heightened significance as a common and potentially life-threatening complication of advanced immunotherapies, particularly chimeric antigen receptor T-cell (CAR-T) therapy, bispecific antibodies, and immune checkpoint inhibitors.
Symptoms range from fever, hypotension, and hypoxia to…
Cytokine Release Syndrome Management Market Know the Scope and Trends
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Cytokine Release Syndrome Management Market - (By Cytokine Type (Tumor Necrosis Factor-TNF, Interleukins-II, Interferons-IFN, Epidermal Growth Factor-EGF), By Therapeutic Application (Cancer, Asthma, Airway Inflammation, Arthritis, Others), By Biomarker Type (Interleukin-10, Interleukin-6, Ferritin, Cluster of Differentiation-163), By Route of Administration (Oral, Intravenous), By End User (Hospitals, Specialty Clinics, Others)), Trends, Industry Competition Analysis, Revenue and Forecast…
Emerging Trends Influencing The Growth Of The Cytokine Release Syndrome Treatmen …
The Cytokine Release Syndrome Treatment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
How Big Is the Cytokine Release Syndrome Treatment Market Size Expected to Be by 2034?
The market size for the treatment of cytokine release syndrome has experienced remarkable growth recently. The market value…
Cytokine Release Syndrome Management Market Know the Scope and Trends
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Cytokine Release Syndrome Management Market - (By Cytokine Type (Tumor Necrosis Factor-TNF, Interleukins-II, Interferons-IFN, Epidermal Growth Factor-EGF), By Therapeutic Application (Cancer, Asthma, Airway Inflammation, Arthritis, Others), By Biomarker Type (Interleukin-10, Interleukin-6, Ferritin, Cluster of Differentiation-163), By Route of Administration (Oral, Intravenous), By End User (Hospitals, Specialty Clinics, Others)), Trends, Industry Competition Analysis, Revenue and Forecast…
Key Driver Shaping the Future Cytokine Release Syndrome Treatment Market From 20 …
What Is the Estimated Market Size and Growth Rate for the Cytokine Release Syndrome Treatment Market?
In recent times, the market size for treatments of cytokine release syndrome has seen a rapid increase. The forecast predicts an upsurge from $1.25 billion in 2024 to $1.42 billion in 2025, presenting a compound annual growth rate (CAGR) of 13.7%. A growth surge during the historical period can be credited to factors such as…
Cytokine Market Size, Share, Growth Report and Forecast 2024-2032
According to the report by Expert Market Research (EMR), the global cytokine market is projected to grow at a CAGR of 6% between 2024 and 2032. Aided by the burgeoning applications in medical and research fields, the market is expected to grow significantly by 2032.
Cytokines are a broad category of small proteins that are crucial in cell signalling. Their role is primarily related to immune and inflammatory responses. These proteins…
